- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04218214
Mixed Methods Implementation Evaluation of an Integrated Depression and Microfinance Program for Women in Vietnam (LIFE-DM)
LIFE-DM Implementation Study: A Mixed Methods Implementation Evaluation of an Integrated Depression and Microfinance Program for Women in Vietnam
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Livelihood Integration for Effective Depression Management (LIFE-DM) aims to address the dual challenges of poverty and depression faced by women in Vietnam by integrating evidence-based treatment for depression management and microfinance services. With funding from NIMH, the investigators established initial evidence for the effectiveness of LIFE-DM in reducing depression and improving functioning, social support, self-efficacy, and income at six months. These treatment effects were maintained at twelve months, suggesting that the LIFE-DM program may be an effective strategy to break the cycle of depression and poverty in low-income women.
For the Grand Challenges of Canada (GCC) Transition to Scale Grant, the investigators developed a model to scale up the program in the public health and social system across two provinces, Danang and Thua Thien Hue through 1) the training of local trainers from the psychiatric hospital to support local implementation, 2) development of a supervision model, and 3) use of a learning collaborative.
To evaluate the success of the model, the investigators will conduct a mixed methods implementation study that will assess implementation and patient outcomes according to the RE-AIM framework, as well as identify barriers and facilitators to implementation.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Da Nang, Vietnam
- Commune Health Stations
-
-
Thua Thien Hue
-
Huế, Thua Thien Hue, Vietnam
- Commune Health Stations
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- depression - based on Patient Health Questionnaire Total Score = > 9
- low-income
- female
- ages 18 - 60
Exclusion Criteria:
- psychosis risk
- mania risk
- substance abuse risk
- high suicide risk
- physical disabilities
- significant cognitive impairments
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
LIFE-DM Group
The LIFE-DM group is a 12-session based on Behavior Activation and Problem Solving therapy for depression applied to both mood problems and livelihood stressors.
Livelihood supports includes training on personal finance, referrals to vocational training, and microfinance loans of 2 million VND.
The group is provided at the local commune health stations, and facilitated by primary care health provider and a lay community provider from the Women's Union.
|
Livelihood Integration for Effective Depression Management (LIFE-DM) program aims to address the dual challenges of poverty and depression by integrating evidence-based treatment for depression management and microfinance services.
The LIFE-DM group is a 12-session based on Behavior Activation and Problem Solving therapy for depression applied to both mood problems and livelihood stressors.
Livelihood supports includes training on personal finance, referrals to vocational training, and access to microfinance loans.
The group is provided at the local commune health stations, and facilitated by primary care health provider and a lay community provider from the Women's Union.
The intervention generally lasts about 3-4 months.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Provider Adoption of LIFE-DM and Depression Care - Count
Time Frame: one year
|
Delivery of LIFE-DM and depression care components (Counts of depression care components delivered - # of screening, assessment, LIFEDM, individual therapy, medication, loans)
|
one year
|
Provider Adoption of LIFE-DM and Depression Care - Percentage
Time Frame: one year
|
Delivery of LIFE-DM and depression care components (% of depression care components delivered - screening, assessment, LIFEDM, individual therapy, medication, loans based on eligible cases)
|
one year
|
Patient Depression Scores (PHQ) Change from Baseline to 6 month
Time Frame: 0, 6 months
|
Patients will be assessed for depression using self-reported depression measure (PHQ).
The Patient Health Questionnaire (PHQ) is a self-administered version of the PRIME-MD diagnostic instrument for common mental disorders.
The PHQ-9 is the depression module, which scores each of the 9 DSM-IV criteria as "0" (not at all) to "3" (nearly every day).
Total scores are used and they range from 0 to 27, with PHQ-9 scores of 5, 10, 15, and 20 represented mild, moderate, moderately severe, and severe depression, respectively.
|
0, 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Provider Participation
Time Frame: 0-12 months
|
Provider Participation in Training Activities (Count / % of workshop attendance, supervision meetings, and learning collaborative meetings)
|
0-12 months
|
Provider Implementation Quality
Time Frame: throughout the study implementation period, about 1 year
|
Supervisor Rated LIFE-DM session adherence and quality.
Supervision of groups involve observation of group facilitation by supervisors, who provide adherence and quality ratings of sessions.
Each item is assessed on a 4 point scale - 0 (did not do), 1 (delivered but poor), 2 (average), and 3 (excellent).
The items are averaged to provide a session specific score of adherence and quality.
Session adherence / quality scores are used to compute provider level adherence and quality averages.
Each supervisor was expected to provide ratings for a minimum of 3 assessments out of the 12 group sessions.
These session ratings are used to compute the average adherence and quality score for each provider.
|
throughout the study implementation period, about 1 year
|
Implementation Barriers and Facilitators
Time Frame: one year
|
Qualitative Interviews of Providers and Program Staff to Assess Barriers and Facilitators of Implementation
|
one year
|
Change in Patient Functioning
Time Frame: 0 and 6 months
|
Patient - SF-12 - Change in functioning from baseline to 6 months.
The SF-12 Health Survey is a 12-item subset of the SF-36v2™ that measures the same eight domains of health (Physical Functioning, Role-Physical, Bodily Pain, General Health, Vitality, Social Functioning, Role-Emotional, Mental Health).
It is a brief, reliable measure of overall health status.
Scores are calibrated so that 50 is the average score or norm.
This norm-based score allows comparison among the three surveys and across the more than 19,000 studies published in the past 20 years
|
0 and 6 months
|
Change in Patient Family Functioning
Time Frame: 0 and 6 months
|
Patient - McMaster Family Functioning Scale - Change from baseline to 6 months.
This is a 12 item scale (on a 4 point scale).
the average score across items is used to determine the degree of problematic family functioning.
A score of 2.00 or above indicates problematic family functioning.
The higher the score, the more problematic the family member perceives the family's overall functioning.
|
0 and 6 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2017-0716
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
-
Gerbera Therapeutics, Inc.Not yet recruitingPostpartum Depression | Depression, Postpartum | Postnatal Depression | Post-partum Depression | Post-Natal DepressionUnited States
Clinical Trials on LIFE-DM Group (Integrated Depression and Livelihood Group Intervention)
-
Fundacio d'Investigacio en Atencio Primaria Jordi...Hospital Universitari Vall d'Hebron Research Institute; Centre d'Higiene Mental...UnknownDepressive DisordersSpain
-
Kjeld SchmiegelowOdense University Hospital; Aarhus University Hospital; Aalborg University HospitalUnknown
-
Kjeld SchmiegelowOdense University Hospital; Aarhus University Hospital; Aalborg University HospitalUnknown
-
RANDNational Institute of Mental Health (NIMH); Danang Psychiatric HospitalCompleted
-
Scott & White Health PlanCompletedChronic IllnessUnited States
-
Massachusetts General HospitalAmerican Society of Clinical OncologyCompletedNon-small Cell Lung CancerUnited States
-
The University of Hong KongCompleted
-
Pontificia Universidade Católica do Rio Grande...Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.Not yet recruitingFrailty | Aging | Physical Disability
-
Universidad Complutense de MadridRecruiting
-
National Taiwan Normal UniversityRecruitingAging | Exercise Training | Neurocognitive FunctionTaiwan